Cargando…

Epigenetic determinants of metastasis

Genetic analyses of cancer progression in patient samples and model systems have thus far failed to identify specific mutational drivers of metastasis. Yet, at least in experimental systems, metastatic cancer clones display stable traits that can facilitate progression through the many steps of meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Saroor A., Vanharanta, Sakari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423227/
https://www.ncbi.nlm.nih.gov/pubmed/27756687
http://dx.doi.org/10.1016/j.molonc.2016.09.008
_version_ 1783234901695266816
author Patel, Saroor A.
Vanharanta, Sakari
author_facet Patel, Saroor A.
Vanharanta, Sakari
author_sort Patel, Saroor A.
collection PubMed
description Genetic analyses of cancer progression in patient samples and model systems have thus far failed to identify specific mutational drivers of metastasis. Yet, at least in experimental systems, metastatic cancer clones display stable traits that can facilitate progression through the many steps of metastasis. How cancer cells establish and maintain the transcriptional programmes required for metastasis remains mostly unknown. Emerging evidence suggests that metastatic traits may arise from epigenetically altered transcriptional output of the oncogenic signals that drive tumour initiation and early progression. Molecular dissection of such mechanisms remains a central challenge for a comprehensive understanding of the origins of metastasis.
format Online
Article
Text
id pubmed-5423227
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54232272017-08-15 Epigenetic determinants of metastasis Patel, Saroor A. Vanharanta, Sakari Mol Oncol Review Articles Genetic analyses of cancer progression in patient samples and model systems have thus far failed to identify specific mutational drivers of metastasis. Yet, at least in experimental systems, metastatic cancer clones display stable traits that can facilitate progression through the many steps of metastasis. How cancer cells establish and maintain the transcriptional programmes required for metastasis remains mostly unknown. Emerging evidence suggests that metastatic traits may arise from epigenetically altered transcriptional output of the oncogenic signals that drive tumour initiation and early progression. Molecular dissection of such mechanisms remains a central challenge for a comprehensive understanding of the origins of metastasis. John Wiley and Sons Inc. 2017-01-03 2017-01 /pmc/articles/PMC5423227/ /pubmed/27756687 http://dx.doi.org/10.1016/j.molonc.2016.09.008 Text en © 2016 The Authors. Published by FEBS Press and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Patel, Saroor A.
Vanharanta, Sakari
Epigenetic determinants of metastasis
title Epigenetic determinants of metastasis
title_full Epigenetic determinants of metastasis
title_fullStr Epigenetic determinants of metastasis
title_full_unstemmed Epigenetic determinants of metastasis
title_short Epigenetic determinants of metastasis
title_sort epigenetic determinants of metastasis
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423227/
https://www.ncbi.nlm.nih.gov/pubmed/27756687
http://dx.doi.org/10.1016/j.molonc.2016.09.008
work_keys_str_mv AT patelsaroora epigeneticdeterminantsofmetastasis
AT vanharantasakari epigeneticdeterminantsofmetastasis